57(top 2%)
papers
3.6K(top 1%)
citations
30(top 1%)
h-index
54(top 1%)
g-index
59
all documents
3.8K
doc citations
1.3K
citing journals

Top Articles

#TitleJournalYearCitations
1Cost of Cancer Care: Issues and ImplicationsJournal of Clinical Oncology2007307
2The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancerAnnals of Oncology2005301
3Patterns of breast carcinoma treatment in older womenCancer2000264
4Changing Gender Prevalence of Stone DiseaseJournal of Urology2007255
5Pay for Performance, Quality of Care, and Outcomes in Acute Myocardial InfarctionJAMA - Journal of the American Medical Association2007254
6A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry SponsorsNew England Journal of Medicine2002190
7The Economic Burden of Allergic RhinitisPharmacoeconomics2004182
8Prescription of QT-prolonging drugs in a cohort of about 5 million outpatientsAmerican Journal of Medicine2003164
9Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancerSupportive Care in Cancer2007130
10Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood culturesDiagnostic Microbiology and Infectious Disease2006115
11The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsCancer2003101
12Personality and Health Care Decision-Making StyleJournals of Gerontology - Series B Psychological Sciences and Social Sciences200792
13Decision making and quality of life in the treatment of cancer: a reviewSupportive Care in Cancer200992
14Relationship Between CD4 Count, Viral Burden, and Quality of Life Over Time in HIV-1-Infected PatientsMedical Care200090
15Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United StatesHealth Services Research200683
16Trends in health care resource use for hepatitis C virus infection in the United StatesHepatology200574
17Cost-effectiveness of imatinib versus interferon-? plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaCancer200472
18A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone diseaseSupportive Care in Cancer200171
19Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancerAnnals of Oncology200670
20Challenges in Enrollment of Minority, Pediatric, and Geriatric Patients in Emergency and Acute Care Clinical ResearchAnnals of Emergency Medicine200870
21Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconceptionTheoretical Medicine and Bioethics200364
22Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated careBMC Health Services Research200360
23Views of potential research participants on financial conflicts of interest barriers and opportunities for effective disclosureJournal of General Internal Medicine200651
24Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United StatesJAMA Pediatrics200547
25Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trialsJournal of Clinical Epidemiology200238
26Long-term survival estimates for imatinib versus interferon-? plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaCancer200435
27Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trialsCancer200535
28Can Prospect Theory Explain Risk-Seeking Behavior by Terminally Ill Patients?Medical Decision Making200534
29Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patientsAmerican Heart Journal200531
30Regionalization of Percutaneous Transluminal Coronary Angioplasty and Implications for Patient Travel DistanceJAMA - Journal of the American Medical Association200430
31Views of Potential Research Participants on Financial Conflicts of Interest.Journal of General Internal Medicine200630
32A framework for quality improvement: An analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiativeAmerican Heart Journal200730
33Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort studyPharmacoepidemiology and Drug Safety200529
34Outcomes research related to patient decision making in oncologyClinical Therapeutics200327
35COMPARISON OF HOSPITAL COSTING METHODS IN AN ECONOMIC EVALUATION OF A MULTINATIONAL CLINICAL TRIALInternational Journal of Technology Assessment in Health Care200327
36Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)American Heart Journal200523
37Economic Evaluation of Zoledronic Acid Versus Pamidronate for the Prevention of Skeletal-Related Events in Metastatic Breast Cancer and Multiple MyelomaAmerican Journal of Clinical Oncology: Cancer Clinical Trials200521
38Use and Perceptions of Clinical Practice Guidelines by Internal Medicine PhysiciansAmerican Journal of Medical Quality200720
39Geographic Variations in the Use of Medical and Surgical Therapies for Benign Prostatic HyperplasiaJournal of Urology200619
40Trends in Operator and Hospital Procedure Volume and Outcomes for Percutaneous Transluminal Coronary Angioplasty, 1996 to 2001American Journal of Cardiology200717
41The Insurance Effect on Prescription Drug Expenditures Among the ElderlyMedical Care200414
42Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancerBone Marrow Transplantation200313
43How Changes In Drug-Safety Regulations Affect The Way Drug And Biotech Companies Invest In InnovationHealth Affairs200613
44Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced AnaemiaPharmacoeconomics200612
45Parents' reported preference scores for childhood atopic dermatitis disease statesBMC Pediatrics200410
46Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialAmerican Heart Journal200610
47Patterns of breast carcinoma treatment in older womenCancer20009
48Analytic Considerations in Economic Evaluations of Multinational Cardiovascular Clinical TrialsValue in Health20067
49Perceived Racial/Ethnic Bias in Healthcare in Durham County, North Carolina: A Comparison of Community and National SamplesNorth Carolina Medical Journal20056
50Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samplesNorth Carolina Medical Journal20056